Recent Finacing
Recent Raise
PanTera uses a patented photo‑nuclear gamma process to convert radium‑226 into radium‑225 (decaying to clinical‑grade actinium‑225), operating a Belgium production facility and supplying pharmaceutical partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at PanTera.
